Executive Summary

Oct 2019
PROSPECTS
Topical analgesics/anaesthetic drives value growth of analgesics

Topical analgesics/anaesthetic remained dominant in value size of analgesics and recorded robust growth in 2019. Long working hours increased the number of people suffering from back or waist pain.

Consumers favour acetaminophen for its mild side effects and wide choice

One major barrier to using systemic analgesics in Taiwan is side effects such as stomach ache. Acetaminophen has the advantage over other types of analgesics as it does not upset the stomach, and “gentle to stomach” is a commonly-used claim for acetaminophen products.

Unit price of analgesics rises to reflect increasing production cost

In 2016, Taiwan Food and Drug Administration (FDA) announced Good Distribution Practice for Medical Products (GDP), which set up quality standards for drug distribution from manufacturers to outlets to ensure drug quality. The rule came into effect later in 2019.

COMPETITIVE LANDSCAPE
GSK Consumer Healthcare leads sales supported by its product innovations

Panadol remained the leading brand in analgesics in 2019. In addition to its high brand awareness among Taiwanese consumers, the brand’s innovations in new products and features spurred sales.

Leading brands sought to build relationships with consumers via local endorsers

When it comes to over-the-counter drugs, consumers in Taiwan heavily rely on advertising for their product choices. To create connection with consumers in Taiwan, many brands chose local celebrities as endorsers.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Taiwan

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Taiwan with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Taiwan, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Taiwan market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Taiwan?
  • What are the major brands in Taiwan?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Taiwan - Category analysis

HEADLINES

PROSPECTS

Topical analgesics/anaesthetic drives value growth of analgesics
Consumers favour acetaminophen for its mild side effects and wide choice
Unit price of analgesics rises to reflect increasing production cost

COMPETITIVE LANDSCAPE

GSK Consumer Healthcare leads sales supported by its product innovations
Leading brands sought to build relationships with consumers via local endorsers

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Taiwan - Industry Overview

EXECUTIVE SUMMARY

Tightened drug subsidies support growth of OTC products in retail market
Rising drug unit price reflects increasing cost due to Good Distribution Practice
Consumers lost trust in local brands as several items found unqualified and recalled
Chemists/Pharmacies underwent strategic partnerships to expand share
Rising health awareness and reduced subsidies for OTC drugs support growth

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format and Category: % Value 2019
Table 16 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources